A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, dementia and Parkinson’s disease.
The new study by scientists at Nottingham Trent University will look at whether treatment can be delivered to the brain via specialised microbubbles.
The researchers believe the cure for Alzheimer’s, Parkinson’s and dementia could lie in the use of non-invasive techniques.
They hope that when used in combination with ultrasound, these tiny bubbles can open the body’s protective blood brain barrier and allow the medication inside to pass through and begin treating the intended area.
The blood brain barrier prevents harmful substances and toxins from reaching the brain – but this also means that potentially important treatments for these diseases are prevented from reaching the brain.
Researchers hope the barrier can be temporarily opened to allow stem cell therapies to cross, and repair and reverse the damage in the brain.
The ultrasound would be used with MRI so that the physiological effect in the brain could be monitored in real-time.
The team is also investigating the potential for using light particles to give a boost of energy to the cells in the brain and blood brain barrier so they can heal naturally and effectively as quickly as possible.
Dr Gareth Cave, head of the nanoscience and drug delivery group in NTU’s School of Science and Technology, said: “These are illnesses that do not discriminate and once they have taken hold, they rob people of the ones they love the most and valuable years together.
“By harnessing knowledge spanning a range of fields, we are pursuing a totally different and truly innovative approach.
“We believe the cure for Alzheimer’s, Parkinson’s and dementia could lie in the use of non-invasive techniques and natural materials.
“These deeply powerful yet far safer tools for combatting the symptoms of these diseases could pave the way for routine treatments that transform – and save – the lives of sufferers.”
The development of a laboratory model of a 3D blood brain barrier– using cultures of human brain cells – in order to rapidly and effectively screen potential therapeutic targets, is a key of the project.
Data suggests there are more than 944,000 people in the UK who have dementia.
The number of people with the condition is increasing because people are living longer, and it is estimated that by 2030, there will be more than one million people in the UK with dementia.
The work is being funded by more than £1 million from the Eranda Rothschild Foundation.
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here